2m 2m 2m 2m 2m 2m 2m
iShs Biotechnology (IBB)
NASDAQ
$214.88+$1.32 (+0.62%)
Price as of Aug 24, 2026 5:02 AM EDT- 53.11%1-Year Change
iShs Biotechnology (IBB)
$214.88+$1.32 (+0.62%)
- 235Holdings Count
- $10.6BTotal Assets
- 47.01%Top 10 Percentage
Holdings
Holding | Latest Close | Shares Held | Weight %
| Market Value |
|---|---|---|---|---|
AMGNAmgen | $439.33 | 2.1M | 8.48% | $899.0M |
VRTXVertex Pharma | $548.05 | 1.6M | 7.95% | $842.7M |
GILDGilead Sciences | $146.12 | 5.2M | 7.03% | $744.9M |
REGNRegeneron Pharma | $834.04 | 754,481 | 5.88% | $623.7M |
ARGXarGEN-X SpADR | $1,039.78 | 388,473 | 3.80% | $403.3M |
MRNAMODERNA | $145.13 | 2.7M | 3.42% | $362.2M |
NTRANatera | $332.03 | 1.0M | 3.13% | $331.7M |
$209.46 | 1.4M | 2.84% | $301.4M | |
ILMNIllumina | $219.40 | 1.1M | 2.27% | $240.6M |
BIIBBiogen | $216.78 | 1.1M | 2.21% | $234.6M |
ALNYAlnylam Pharma | $236.22 | 994,103 | 2.15% | $227.9M |
ONCBeOne Medi Sp ADR | $374.47 | 595,290 | 2.07% | $219.8M |
INSMInsmed | $125.77 | 1.6M | 1.89% | $200.8M |
INCYIncyte | $127.81 | 1.5M | 1.78% | $188.3M |
$513.12 | 306,836 | 1.51% | $159.9M | |
ROIVROIVANT SCIENCES | $36.30 | 3.9M | 1.34% | $142.2M |
GMABGENMAB SP ADR | $33.45 | 3.9M | 1.23% | $130.5M |
ASNDAscendis Pharma Br | $253.29 | 462,306 | 1.11% | $117.8M |
NBIXNeurocrine Biosc | $152.57 | 738,646 | 1.07% | $113.0M |
MEDPMedpace Holdings | $620.75 | 172,023 | 0.99% | $105.4M |
BBIOBRIDGEBIO PHARMA | $81.50 | 1.3M | 0.99% | $104.8M |
CRLCharles Riv Lab | $295.19 | 355,863 | 0.98% | $103.7M |
EXELExelixis | $54.08 | 1.8M | 0.92% | $97.8M |
BMRNBiomarin Pharm | $66.70 | 1.4M | 0.91% | $96.3M |
HALOHalozyme Therape | $108.17 | 877,750 | 0.88% | $93.1M |
ARWRArrowhead Phrmct | $87.11 | 989,381 | 0.82% | $86.5M |
$72.24 | 1.2M | 0.80% | $84.3M | |
MDGLMadrigal Pharmct | $516.74 | 162,205 | 0.79% | $84.2M |
BNTXBioNTech Sp ADR | $116.57 | 683,727 | 0.72% | $75.8M |
RGENRepligen | $181.13 | 398,864 | 0.68% | $71.9M |
Holdings by Sector
- Healthcare100.00%